[Eye pigmentation disorders in patients treated with phenothiazines].
D004295:Dihydroxyphenylalanine / Q000378:metabolism; D005128:Eye Diseases / Q000139:chemically induced* / Q000201:enzymology / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008543:Melanins / Q000096:biosynthesis; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism; D010640:Phenothiazines / Q000009:adverse effects*; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000201:enzymology / Q000378:metabolism; D013831:Thiamine / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
D008543:Melanins; D010640:Phenothiazines; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D009074:Melanocyte-Stimulating Hormones; D010088:Oxidoreductases; D013831:Thiamine
Les troubles pigmentaires de l'oeil chez les malades traités par les phénothiazines.